Trial intelligence / Profile preview

Intranasal Insulin for Gulf War Multisymptom Illness

NCT01802944Phase 2Unknown

Start
Apr 2014
Primary completion
Dec 2017
Modality
Peptides
Countries
1
01

Overview

A Phase 2 trial of intranasal insulin in Chronic Multisymptom Illness (CMI). Status: unknown.

02

Drugs

intranasal insulin
03

Conditions

Chronic Multisymptom Illness (CMI)

Beyond the preview

Go deeper on NCT01802944.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01802944.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call